Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Beth Wensley
Introduction
Beth Wensley is a prominent inventor based in Lexington, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of multispecific molecules that target specific proteins involved in immune responses.
Latest Patents
Wensley holds a patent for her work on anti-TIGIT and anti-CD96 antibodies. This patent provides multispecific molecules that specifically bind to CD96 and/or TIGIT, along with isolated antibodies that target these proteins. The patent also includes pharmaceutical compositions, nucleic acids encoding these molecules, expression vectors, and host cells for their production. Furthermore, it outlines methods for treating subjects using these innovative molecules and antibodies.
Career Highlights
Beth Wensley has established herself as a key figure in her field through her work at Agenus Inc. Her research focuses on advancing therapeutic options for various diseases by leveraging her expertise in antibody development.
Collaborations
Wensley collaborates with talented individuals such as Dhan Sidhartha Chand and Zahra Jawad, contributing to a dynamic research environment that fosters innovation.
Conclusion
Beth Wensley's contributions to biotechnology, particularly through her patent on anti-TIGIT and anti-CD96 antibodies, highlight her role as an influential inventor in the field. Her work continues to pave the way for advancements in therapeutic treatments.